- Report
- August 2025
- 378 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 479 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 471 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 197 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 291 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 383 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 177 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 189 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 280 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 283 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 553 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 277 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 280 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 472 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 378 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 284 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 179 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 394 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 362 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 274 Pages
Global
From €5208EUR$5,850USD£4,501GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more